PUBLICATIONS - New from Clinica Reports - Blood and Tissue Growth Factors
This article was originally published in Clinica
Executive summary The competitive environment of the growth factor market is extremely dynamic - driven in part by advances in drug delivery and gene therapy technology. Moreover, rapid developments in cell manipulation and genetics now cater for advances in tissue modulation previously thought many years away. With new products entering the market place, massive growth is expected in the next few years.
You may also be interested in...
Turku, Finland-based Forendo Pharma has entered into a license and collaboration deal with Novartis involving the identification of novel drugs to treat chronic liver diseases.
Three accelerated assessment requests will either be granted or rejected this week at the European Medicines Agency.
A new work sharing pilot has been launched to evaluate jointly generic drugs intended for launch in Singapore and Malaysia.